SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015813
Filing Date
2023-04-28
Accepted
2023-04-28 16:13:40
Documents
3
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A ubx-2023_def_14a.htm DEF 14A 1325142
2 GRAPHIC img248991526_0.jpg GRAPHIC 450450
3 GRAPHIC img248991526_1.jpg GRAPHIC 178570
  Complete submission text file 0000950170-23-015813.txt   2192146
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38470 | Film No.: 23866303
SIC: 2834 Pharmaceutical Preparations